US Patent Issued to ELI LILLY and Co. on Oct. 28 for "Methods of treating cancer using anti-CD137 antibodies" (Indiana, Connecticut, New York Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,771, issued on Oct. 28, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Methods of treating cancer using anti-CD137 antibodies" was invented by Christopher Carl Frye (Bargersville, Ind.), Michael Dewain Kalos (Brooklyn, N.Y.), Helen Kotanides (Norwalk, Conn.) and Stephanie Lynn Sandefur (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies that bind to human CD137 and display agonist activity, and are useful for treating solid and hematological tumors alone and in combination with chemotherapy and ionizing radiation."

The patent was filed on Nov. 1, 2022, under Application No. 18/051,761.

*...